Vytrus Biotech SA
MAD:VYT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vytrus Biotech SA
MAD:VYT
|
ES |
|
A
|
American Coastal Insurance Corp
F:0UI
|
US |
|
H
|
HAL Trust
OTC:HALFF
|
NL |
|
Open House Group Co Ltd
F:O4H
|
JP |
|
Americold Realty Trust Inc
NYSE:COLD
|
US |
|
Sabre Resources Ltd
ASX:SBR
|
AU |
|
M
|
Matson Inc
F:68M
|
US |
|
5
|
5N Plus Inc
SWB:EMB
|
CA |
Intrinsic Value
Is VYT undervalued or overvalued?
See the intrinsic value estimate for Vytrus Biotech SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Vytrus Biotech Does
Vytrus Biotech develops plant-based active ingredients for the cosmetics and personal care industry. It uses plant stem cell and plant tissue culture technology to create concentrated ingredients that skincare, haircare, and beauty brands can add to their products. In simple terms, it sells specialized ingredient formulas rather than finished consumer products.
- Headquarters
- Spain ES
- Employees
- 28
- IPO date
- Mar 24, 2022
Earnings Waterfall
Vytrus Biotech SA
The intrinsic value for Vytrus Biotech SA (VYT) under the Base Case is hidden EUR.
Compared with the current market price of 15 EUR, the stock appears hidden.
